Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1996
10/29/1996US5569603 Parasiticide
10/29/1996US5569457 Administering a betaine compound with influenza vaccine
10/29/1996US5569454 Methods of treating infection using natural killer stimulatory factor
10/24/1996WO1996033414A2 Compounds and methods for diagnosis of leishmaniasis
10/24/1996WO1996033274A1 Helicobacter pylori cagi region
10/24/1996WO1996033273A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions
10/24/1996WO1996033269A1 Vectors and prokaryotes which autocatalytically delete antibiotic resistance
10/24/1996WO1996033220A1 Protective helicobacter antigens
10/24/1996WO1996033219A1 Monoclonal antibodies against hiv-1 and vaccines made thereof
10/24/1996WO1996033208A1 Antibody purification by low-ph hydrophobic interaction chromatoggraphy
10/24/1996WO1996033203A1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof
10/24/1996WO1996032965A1 Cd45rb binding compounds for the prevention of transplant rejection
10/24/1996WO1996032964A1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
10/24/1996WO1996032963A1 Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins
10/24/1996WO1996032962A1 Immunoassay for herpes simplex virus
10/24/1996WO1996032959A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996WO1996032957A1 Modulation of cytokine patterns of human autoreactive t-cell clones
10/24/1996WO1996032932A1 Dna vaccines against rotavirus infections
10/24/1996WO1996032841A1 Novel therapeutic binding molecule complexes
10/24/1996CA2218691A1 Novel therapeutic binding molecule complexes
10/24/1996CA2218599A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996CA2218385A1 Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins
10/24/1996CA2217496A1 Protective helicobacter antigens
10/24/1996CA2216936A1 Modulation of cytokine patterns of human autoreactive t-cell clones
10/23/1996EP0738736A1 Monoclonal antibodies to gp130, and their uses
10/23/1996EP0738735A2 Aminoterminal propeptide of type I procollagen, antibody thereto and assay method using it
10/23/1996EP0738322A1 T cell antigen receptor v region proteins and methods of preparation thereof
10/23/1996EP0738283A1 New polyaminocarboxylate chelators
10/23/1996EP0738281A1 Peptides and methods against psoriasis
10/23/1996EP0738278A1 Expression of surface layer proteins
10/23/1996EP0738156A1 Methods and compositions for inhibiting thrombogenesis
10/23/1996EP0528886B1 Beta cell antigen
10/23/1996EP0477339B1 Hydroxyapatite-antigen conjugates and methods for generating a poly-ig immune response
10/23/1996EP0431072B1 Recombinant fowlpox virus
10/23/1996EP0427767B1 Vaccine
10/23/1996EP0422125B1 Platelet blocking peptides
10/23/1996EP0416094B1 Parathyroid hypertensive factor
10/23/1996EP0276262B1 Merozoite surface antigen of plasmodium falciparum
10/23/1996CN1134175A Viral vector with bovine viral diarrhea virus (BVDV) antigens
10/23/1996CN1134174A Modified plant viruses as vectors of heterologous peptides
10/23/1996CN1134173A Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
10/23/1996CN1134113A Method for inducing antigen-specific T cell tolerance
10/23/1996CN1134112A Vaccine and method for treatment of chlamydial infections
10/23/1996CN1134109A Chemically-defined non-polymeric valency plateform molecules and conjugates thereof
10/23/1996CN1133886A Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them
10/22/1996US5567610 Method of producing human monoclonal antibodies and kit therefor
10/22/1996US5567603 HIV-3 retrovirus and its use
10/22/1996US5567594 Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
10/22/1996US5567582 Dna sequences
10/22/1996CA1338663C Biosynthetic osteogenic proteins and osteogenic devices containing them
10/17/1996WO1996032641A1 Novel protein from dirofilaria immitis and method for immunodiagnosis of heartworm in mammals
10/17/1996WO1996032495A1 Monoclonal antibody specific for human 4-1bb and cell line producing same
10/17/1996WO1996032485A1 Phospholipase c homolog
10/17/1996WO1996032483A1 Immune-evading proteins
10/17/1996WO1996032482A1 Bacteriocins
10/17/1996WO1996032479A1 Hookworm vaccine
10/17/1996WO1996032478A1 Altered polypeptides with increased half-life
10/17/1996WO1996032417A1 Antibodies against heart muscle actin
10/17/1996WO1996032416A1 Novel anti-aids immunotoxins
10/17/1996WO1996032401A1 Quillaja saponin adjuvant and vaccine formulation containing same
10/17/1996WO1996032152A1 Pulmonary administration of dry powder alpha 1-antitrypsin
10/17/1996WO1996032149A1 Pulmonary delivery of aerosolized medicaments
10/17/1996WO1996032142A1 Skin patch for use in contact immunotherapy
10/17/1996WO1996032137A2 Methods of inducing immune tolerance using immunotoxins
10/17/1996WO1996032132A1 Peptides of nematode tubulin and methods of use
10/17/1996WO1996032128A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996WO1996032106A1 Aglyco products
10/17/1996WO1996032102A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/17/1996WO1996021020A3 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
10/17/1996WO1996017951A3 Identification of genes responsible for in vivo survival of microorganisms
10/17/1996CA2393381A1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides
10/17/1996CA2218208A1 Pulmonary administration of dry powder alpha 1-antitrypsin
10/17/1996CA2217977A1 Immune-evading proteins
10/17/1996CA2217947A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996CA2216858A1 Phospholipase c homolog
10/17/1996CA2216210A1 Novel anti-aids immunotoxins
10/17/1996CA2192597A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/16/1996EP0737750A2 Expression of exogenous polynucleotide sequences in a vertebrate
10/16/1996EP0737747A2 Cytoplasmatic expression in E. coli of antibodies, antibody fragments and fusions thereof
10/16/1996EP0737472A1 Single-shot vaccine formulation
10/16/1996EP0737311A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases
10/16/1996EP0737251A1 Antibodies to egf receptor and their antitumour effect
10/16/1996EP0737250A1 Humanized antibodies and uses thereof
10/16/1996EP0737247A1 Method and reagent for inhibiting hepatitis c virus replication
10/16/1996EP0737205A1 T-cell epitopes
10/16/1996EP0737085A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS)
10/16/1996EP0737075A1 Ileal bile acid transporter compositions and methods
10/16/1996EP0610179B1 Target specific antibody-superantigen conjugates and their preparation
10/16/1996EP0601062B1 Sirs vaccine and diagnosis method
10/16/1996EP0601052B1 Therapeutic method for the treatment of iddm
10/16/1996EP0543945B1 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus
10/16/1996EP0432168B1 Genetically engineered coccidiosis vaccine
10/16/1996EP0429477B1 Synthetic vaccine against aids virus
10/16/1996EP0414755B1 Interaction system comprising a surfactant-stabilized disperse aqueous phase containing an antibody or antibody fragment
10/16/1996CN1133616A A novel nuclear mitotic phosphoprotein:mitosin
10/16/1996CN1133599A Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
10/16/1996CN1133597A Peptide capable of inducing immune response against HIV and AIDS preventive or remedy containing the peptide
10/16/1996CN1133594A Hsv-2 UL26 gene, capsid proteins, immunoassays and protease inhibitors
10/16/1996CN1133564A The Cloning of duffy blood group antigen
10/16/1996CN1133192A Monoclonal antibody with idiocrasy to pneumonia chlamydia and preparation process
1 ... 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 ... 1823